-
Budget Impact of Introducing Accuchek® Smartguide Real-Time Continuous Glucose Monitoring (RtCGM) Solution for Diabetes Management in Portugal
Sep 9, 2025, 16:22 PM -
The Next Steps Matter? New Cancer Medicines and Their Indication Extensions in Europe 2010-2020
Sep 9, 2025, 16:22 PM -
Examining the Relationship Between the NICE WTP Threshold and the Severity Modifier
Sep 9, 2025, 16:22 PM -
Adoption and Evidence Generation in NICE Early Value Assessments (EVA) for Medtech: Trends Across 2023-2025
Sep 9, 2025, 16:22 PM -
Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in the Netherlands: Insights From CHOICE-CSU 2 Study
Sep 9, 2025, 16:22 PM -
Evolution of High-Efficacy Therapies for Relapsing Multiple Sclerosis: Does Innovation Meet Patient Preferences?
Sep 9, 2025, 16:22 PM -
Are Discrete Choice Experiment Results Robust to Omitted Attributes? Evidence From a Vaccine Study
Sep 9, 2025, 16:22 PM -
Incidence of Treatment-Related Adverse Events From Immune Checkpoint Inhibitors: A Meta-Analysis of Randomized Clinical Trials
Sep 9, 2025, 16:22 PM -
Optimizing Colorectal Cancer Screening in the Czech Republic: Cost-Effectiveness of Lowering the Starting Age to 45 and Introducing an Upper Limit
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Ga-PSMA-11 PET/CT Imaging Followed by Lu-PSMA-617 vs. Standard of Care in Metastatic Castrate-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM -
Piloting Structured Expert Elicitation: An Exploratory Case Study of Practical Implementation
Sep 9, 2025, 16:22 PM -
Workforce and Environmental Impact of Home-Based vs. Hospital-Based Administration of Second-Line MS Therapies in the Netherlands: A Comparative Analysis of Personnel Time and Carbon Footprint
Sep 9, 2025, 16:22 PM -
Improving Kidney Exchange Program Effectiveness and Equity by Using Allele and Eplet HLA Compatibility Technologies
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of the Prostate Health Index (PHI) Test After a Prostate-Specific Antigen (PSA) Test in UK
Sep 9, 2025, 16:22 PM -
US Payer Assessment of the Utility and Impact of Value Dossiers on Decision Making
Sep 9, 2025, 16:22 PM -
Public Health and Economic Impact of RSVpreF Maternal Vaccination Among Infants in Five Asian Countries
Sep 9, 2025, 16:22 PM -
Trends and Tensions in NICE Severity Modifiers: Analyzing the Acceptance and Critique of Manufacturer Severity Modifier Proposals in Recent Appraisals
Sep 9, 2025, 16:22 PM -
Clinical Outcomes Associated With Pembrolizumab Immunotherapy in Mesothelioma: A Systematic Review
Sep 9, 2025, 16:22 PM -
The Association Between Schizophrenia and Cardiovascular Diseases: A Retrospective Cohort Study in German Primary Care
Sep 9, 2025, 16:22 PM -
Non-Proportional Hazards Network Meta-Analysis in NICE Technology Appraisals Prevalence and Insights
Sep 9, 2025, 16:22 PM
